Vinorelbine and Gemcitabine as Second- Or Third-Line Therapy for Malignant Pleural Mesothelioma
Lung Cancer - Netherlands
doi 10.1016/j.lungcan.2014.03.006
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2014
Authors
Publisher
Elsevier BV